Pharmacotherapy Casebook: A Patient-Focused Approach

1. Preparing for a Rotation/Goals and Objectives/Rounding 2. Ethics of Practice 3. Communications for Pharmacists 4. Federal Laws and Regulations-Liability 5. Medical/Pharmacy Terminology 6. Drug Information/Literature Review/Journal Clubs 7. Physical Assessment 8. Interpretation of Diagnostic Testing and Laboratory Data 9. Pharmacokinetics 10. Calculations 11. Drug Monitoring 12. Nutrition 13. Clinical Community Practice Rotations 14. Pharmaceutical Care Appendix: Charts for collecting and reporting data

[1]  M. Slack,et al.  Effect of information organization on recall of medication instructions. , 1990, Journal of clinical pharmacy and therapeutics.

[2]  T. Laidlaw,et al.  Communication skills in medical school: exposure, confidence, and performance. , 2000 .

[3]  B. Wiman,et al.  The Risk of Recurrent Venous Thromboembolism in Carriers and Non-carriers of the G1691A Allele in the Coagulation Factor V Gene and the G20210A Allele in the Prothrombin Gene , 1999, Thrombosis and Haemostasis.

[4]  W. Aronow,et al.  Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. , 1993, The American journal of cardiology.

[5]  Y. Loke,et al.  Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis , 2000, BMJ : British Medical Journal.

[6]  P. Bath,et al.  Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials. , 2000, Stroke.

[7]  M. Pecherstorfer,et al.  Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy , 1999, Drug safety.

[8]  D. Kiel,et al.  Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis , 2000, Aging.

[9]  B R Canaday,et al.  Documenting Pharmaceutical Care: Creating a Standard , 1994, The Annals of pharmacotherapy.

[10]  D. Salazar,et al.  Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. , 1988, The American journal of medicine.

[11]  R. Herrier,et al.  Obtaining and using patient data. , 1991, American pharmacy.

[12]  J. Delafuente.  A Problem Solving Active-Learning Course in Pharmacotherapy. , 1994 .

[13]  W. A. Zellmer.  Collaborative drug therapy management. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  R. Popenoe,et al.  Perceptions and Misperceptions of Skin Color , 1995, Annals of Internal Medicine.

[15]  W. Donnelly.  The Language of Medical Case Histories , 1997, Annals of Internal Medicine.

[16]  P. J. Byard,et al.  Effect of high-dose ibuprofen in patients with cystic fibrosis. , 1995, The New England journal of medicine.

[17]  W. Busse,et al.  Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. , 1999, The Journal of allergy and clinical immunology.

[18]  M. Gales.  Oral Antihypertensives for Hypertensive Urgencies , 1994, The Annals of pharmacotherapy.

[19]  Mary Budd Rowe.  Pausing principles and their effects on reasoning in science , 1980 .

[20]  C. F. Herreid.  Case Studies in Science--A Novel Method of Science Education. , 1994 .

[21]  G. Bassotti,et al.  Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation , 2000, Gut.

[22]  A. Blei.  Diagnosis and treatment of hepatic encephalopathy. , 2000, Bailliere's best practice & research. Clinical gastroenterology.

[23]  Joseph T. DiPiro,et al.  Pharmacotherapy: A pathophysiologic approach , 1992 .

[24]  Thomson,et al.  Primary gastroduodenal prophylaxis with omeprazole for non‐steroidal anti‐inflammatory drug users , 1998, Alimentary pharmacology & therapeutics.

[25]  M. Mulvihill.  Human Diseases: A Systemic Approach , 1991 .

[26]  R. Higashida,et al.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. , 1998, Stroke.

[27]  H. Walton,et al.  Essentials of problem‐based learning , 1989, Medical education.

[28]  C. Moote,et al.  Efficacy and safety of potassium infusion therapy in hypokalemic critically ill patients. , 1991 .

[29]  G. Guyatt,et al.  A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1998, The New England journal of medicine.

[30]  Zheng-Ming Chen,et al.  CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke , 1997, The Lancet.

[31]  R. Rogers,et al.  Obstructive sleep apnea. , 1996, The New England journal of medicine.

[32]  W. Rubin,et al.  Medical treatment of peptic ulcer disease. , 1991, The Medical clinics of North America.

[33]  J. Howland,et al.  Does patient education cause side effects? A controlled trial. , 1990, The Journal of family practice.

[34]  E. Thompson,et al.  Pulmonary-embolic disease. , 1962, Lancet.

[35]  Nancy Winslade,et al.  Large Group Problem-Based Learning: A Revision from Traditional to Pharmaceutical Care-Based Therapeutics. , 1994 .

[36]  J. Uribarri.  ACID‐BASE IN RENAL FAILURE: Acidosis in Chronic Renal Insufficiency , 2001, Seminars in dialysis.

[37]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[38]  J. L. Fletcher,et al.  Continuation of warfarin-nafcillin interaction during dicloxacillin therapy. , 1994, Journal of Family Practice.

[39]  J. Devlin,et al.  ASHP therapeutic guidelines on stress ulcer prophylaxis , 1999 .

[40]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[41]  Khan Mk,et al.  Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. , 1999, JAMA.

[42]  B. Brandt.  Effective Teaching and Learning Strategies , 2000, Pharmacotherapy.

[43]  H. Straatman,et al.  Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis , 1999, Alimentary pharmacology & therapeutics.

[44]  P A Poole-Wilson,et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.

[45]  J. Kirscht,et al.  Understanding and improving patient compliance. , 1984, Annals of internal medicine.

[46]  C. Bonwell,et al.  Active learning : creating excitement in the classroom , 1991 .

[47]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[48]  Roger Williams,et al.  Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double‐blind, randomized, dose‐finding multi‐centre study , 2000, European journal of gastroenterology & hepatology.

[49]  Charles A. Hughes,et al.  Using the Pause Procedure to Enhance Lecture Recall , 1987 .

[50]  C. Sorkness,et al.  Potential Interaction between Warfarin and Dicloxacillin , 1996, The Annals of pharmacotherapy.

[51]  J. Aranda‐Michel,et al.  Acute diarrhea: a practical review , 1999, The American Journal of Medicine.

[52]  Interpersonal Communication in Pharmaceutical Care , 1994 .

[53]  L. Weed.  Medical records that guide and teach. , 1968, The New England journal of medicine.

[54]  S. Halvorsen,et al.  Prosthetic heart valve thrombosis during dicloxacillin therapy. , 1999, Scandinavian cardiovascular journal : SCJ.

[55]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[56]  E H Shortliffe,et al.  The evolution of electronic medical records. , 1999, Academic medicine : journal of the Association of American Medical Colleges.

[57]  John Spencer,et al.  Using real patients in problem-based learning: students' comments on the value of using real, as opposed to paper cases, in a problem-based learning module in general practice. , 2001 .

[58]  M Gent,et al.  A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. , 1999, The New England journal of medicine.

[59]  T. LeJemtel,et al.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. , 2000, The New England journal of medicine.

[60]  Diana C. Shakarian.  Beyond Lecture: Active Learning Strategies that Work , 1995 .

[61]  J. Pawlotsky,et al.  Standardization of Hepatitis C Virus RNA Quantification , 2000, Hepatology.

[62]  Abraham G. Hartzema,et al.  Teaching Therapeutic Reasoning through the Case-Study Approach: Adding the Probabilistic Dimension. , 1994 .

[63]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[64]  M. Iliou,et al.  [Torsades de pointes]. , 1993, Archives des maladies du coeur et des vaisseaux.

[65]  A. Chickering,et al.  Seven Principles for Good Practice in Undergraduate Education , 1987, CORE.

[66]  A. Sauvanet,et al.  Risk factors for diabetes mellitus in chronic pancreatitis. , 2000, Gastroenterology.

[67]  P. Marik,et al.  The diagnosis and management of hypertensive crises. , 2000, Chest.

[68]  B. Karp,et al.  Myelinolysis after Correction of Hyponatremia , 1997, Annals of Internal Medicine.

[69]  H. Black,et al.  Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. , 1990, The American journal of cardiology.

[70]  A. Greinacher,et al.  Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. , 2000, Blood.

[71]  P. Ind,et al.  Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid , 1994, The Lancet.

[72]  P K Rangachari,et al.  Active learning: in context. , 1995, The American journal of physiology.

[73]  D. Cook,et al.  Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1999, Critical care medicine.

[74]  Philip D. Harvey,et al.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.

[75]  C U Lehmann,et al.  Active Learning Centre: design and evaluation of an educational World Wide Web site , 2000, Medical informatics and the Internet in medicine.

[76]  B. A. Mueller,et al.  Selection of narcotic analgesics for pain associated with pancreatitis. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[77]  Risk factors for gastrointestinal bleeding in critically ill patients , 1994 .

[78]  R. Dittus,et al.  Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. , 1991, Annals of internal medicine.

[79]  W. Frishman,et al.  Management of Hypertensive Urgencies and Emergencies , 1995, Journal of clinical pharmacology.

[80]  Jana Dozier.  None of Your Business , 1989 .

[81]  D D Elliott,et al.  Promoting critical thinking in the classroom. , 1996, Nurse educator.

[82]  D. Drossman,et al.  American Gastroenterological Association medical position statement: irritable bowel syndrome. , 1997, Gastroenterology.

[83]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[84]  L. Strand,et al.  Drug-Related Problems: Their Structure and Function , 1990, DICP : the annals of pharmacotherapy.

[85]  B. Charles,et al.  Pharmacokinetics and Therapeutic Drug Monitoring of Gentamicin in the Elderly , 1999, Clinical pharmacokinetics.

[86]  R. Abbott,et al.  Hyponatremia: evaluating the correction factor for hyperglycemia. , 1999, The American journal of medicine.

[87]  Bruce H. R. Wolffenbuttel,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.

[88]  L. Fried,et al.  Hyponatremia and hypernatremia. , 1997, The Medical clinics of North America.

[89]  Bertram Pitt,et al.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.

[90]  S W Schalm,et al.  Subclinical Hepatic Encephalopathy , 1996, Seminars in liver disease.

[91]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 2001, Chest.